Skip to main navigation Skip to search Skip to main content

Reply to: ‘Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis’

Khalaf Kridin*, Henner Zirpel, Noor Mruwat, Ralf J. Ludwig, Diamant Thaci

*Corresponding author for this work
Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology
Volume38
Issue number4
Pages (from-to)e354-e355
ISSN0926-9959
DOIs
Publication statusPublished - 04.2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

DFG Research Classification Scheme

  • 2.21-05 Immunology

Cite this